会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Composition for cryopreservation comprising nicotinamide, glycerol and red blood cells
    • 用于包含烟酰胺,甘油和红细胞的冷冻保存的组合物
    • US08895236B2
    • 2014-11-25
    • US13368460
    • 2012-02-08
    • Stephen A. LiveseyMichael Brian BurnettJerome ConnorChristopher Todd Wagner
    • Stephen A. LiveseyMichael Brian BurnettJerome ConnorChristopher Todd Wagner
    • A01N1/02A61K35/18
    • A01N1/02A01N1/0226A61K35/18
    • A red blood cell storage composition includes a composition of red blood cells and biochemistry altering reagents, the biochemistry altering reagents being present at a concentration so as to reduce the percent hemolysis of the red blood cells during the freeze-thaw cycle below that of the percent hemolysis of the red blood cells in the absence the biochemistry altering reagents. The red blood cell storage composition preferably includes reagents selected from: modifiers of glycolytic/metabolic components, modifiers of antioxidant potential, effectors of intracellular ionic distribution, modifiers of membrane fluidity, modifiers of cytoskeletal structure, effectors of the cyclooxygenase second messenger pathway, effectors of the lipoxygenase second messenger pathway, effectors of the hexose monophosphate second messenger pathway, effectors of the phosphorylation second messenger pathway, modifiers of specific messenger molecules, and combinations thereof.
    • 红细胞储存组合物包括红细胞和生物化学改变试剂的组合物,所述生物化学改变试剂以浓度存在,以便将冻融循环期间的红细胞溶血百分比降低至百分比以下 在没有生物化学改变试剂的情况下红细胞溶血。 红细胞储存组合物优选包括选自以下的试剂:糖酵解/代谢组分的改性剂,抗氧化剂潜力的改性剂,细胞内离子分布的作用剂,膜流动性的调节剂,细胞骨架结构的改性剂,环加氧酶第二信使途径的作用者, 脂氧合酶第二信使通路,己糖单磷酸第二信使途径的作用子,磷酸化第二信使途径的作用剂,特异信使分子的改性剂及其组合。
    • 10. 发明申请
    • Cryopreservation of human red blood cells
    • 人类红细胞的冷冻保存
    • US20060127375A1
    • 2006-06-15
    • US11334950
    • 2006-01-18
    • Stephen LiveseyMichael BurnettJerome ConnorChristopher Wagner
    • Stephen LiveseyMichael BurnettJerome ConnorChristopher Wagner
    • A61K35/14A01N1/02A61K31/70A61K31/7048A61K31/522A61K31/7012
    • A01N1/02A01N1/0226A61K35/18
    • A red blood cell storage composition includes a composition of red blood cells and biochemistry altering reagents, the biochemistry altering reagents being present at a concentration so as to reduce the percent hemolysis of the red blood cells during the freeze-thaw cycle below that of the percent hemolysis of the red blood cells in the absence the biochemistry altering reagents. The red blood cell storage composition preferably includes reagents selected from: modifiers of glycolytic/metabolic components, modifiers of antioxidant potential, effectors of intracellular ionic distribution, modifiers of membrane fluidity, modifiers of cytoskeletal structure, effectors of the cyclooxygenase second messenger pathway, effectors of the lipoxygenase second messenger pathway, effectors of the hexose monophosphate second messenger pathway, effectors of the phosphorylation second messenger pathway, modifiers of specific messenger molecules, and combinations thereof.
    • 红细胞储存组合物包括红细胞和生物化学改变试剂的组合物,所述生物化学改变试剂以浓度存在,以便将冻融循环期间的红细胞溶血百分比降低至百分比以下 在没有生物化学改变试剂的情况下红细胞溶血。 红细胞储存组合物优选包括选自以下的试剂:糖酵解/代谢组分的改性剂,抗氧化剂潜力的改性剂,细胞内离子分布的作用剂,膜流动性的调节剂,细胞骨架结构的改性剂,环加氧酶第二信使途径的作用者, 脂氧合酶第二信使通路,己糖单磷酸第二信使途径的作用子,磷酸化第二信使途径的作用剂,特异信使分子的改性剂及其组合。